Literature DB >> 24075157

Comparative analysis of the visual and refractive outcomes of an aspheric diffractive intraocular lens with and without toricity.

Elisabeth H Frieling-Reuss1.   

Abstract

PURPOSE: To analyze and compare the postoperative visual and refractive outcomes and patients' visual satisfaction after implantation of an aspheric or an aspheric toric multifocal diffractive intraocular lens (IOL) in eyes with equivalent biometric characteristics.
SETTING: Private clinic, Munich, Germany.
DESIGN: Comparative case series.
METHODS: Patients having cataract surgery were assigned to 1 of 2 groups: aspheric, which had AT Lisa 809M IOL implantation, and aspheric toric, which had AT Lisa 909M IOL implantation (corneal toricity ≥0.75 diopter [D]). Visual and refractive postoperative outcomes were evaluated, as was the patient's ability to perform daily tasks related to vision and the incidence of photic phenomena.
RESULTS: The aspheric group comprised 77 eyes (42 patients) and the aspheric toric group, 26 eyes (17 patients). A significant improvement in corrected distance and near visual acuity was observed postoperatively in both groups, as was a significant reduction in the astigmatic component J0 (P<.01). The aspheric toric group had significantly better uncorrected intermediate visual acuity (P=.01). In both groups, the postoperative astigmatic power vectors and spherical equivalent were within ±0.50 D in 100% of eyes and in more than 88% of eyes, respectively. No statistically significant differences were found in any subjective patient questionnaire item. There was no difference in the incidence of photic phenomena between the groups (P≥0.16).
CONCLUSION: The addition of a toric surface to the aspheric diffractive multifocal platform resulted in a comparable visual performance and ability to perform visual tasks. FINANCIAL DISCLOSURE: The author has no financial or proprietary interest in any material or method mentioned.
Copyright © 2013 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24075157     DOI: 10.1016/j.jcrs.2013.04.034

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  [Multifocal intraocular lens (MIOL) surgery in young non-presbyopic ametropes : Reasonable and safe?]

Authors:  A Frings; J Steinberg; S J Linke; V Druchkiv; T Katz
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

2.  Bilateral implantation of +3.0 D multifocal toric intraocular lenses: results of a US Food and Drug Administration clinical trial.

Authors:  Robert Lehmann; Satish Modi; Bret Fisher; Magda Michna; Michael Snyder
Journal:  Clin Ophthalmol       Date:  2017-07-20

3.  Influence of the level of monovision on visual outcome with an extended range of vision intraocular lens.

Authors:  Béatrice Cochener
Journal:  Clin Ophthalmol       Date:  2018-11-12

4.  Comparison of visual outcomes after bilateral implantation of two intraocular lenses with distinct diffractive optics.

Authors:  André Lins de Medeiros; Flavio Jones Saraiva; Camila Ishii Iguma; Danilo Varela Kniggendorf; Guilherme Alves; Mario Augusto Pereira Dias Chaves; Cesar Vilar; Antonio Francisco Pimenta Motta; Pedro Carlos Carricondo; Celso Takashi Nakano; Walton Nosé; Wilson Takashi Hida
Journal:  Clin Ophthalmol       Date:  2019-08-29

Review 5.  Dioptric power and refractive behaviour: a review of methods and applications.

Authors:  Alan Rubin; Tanya Evans; Nabeela Hasrod
Journal:  BMJ Open Ophthalmol       Date:  2022-04-01

6.  Clinical Outcomes after Uncomplicated Cataract Surgery with Implantation of the Tecnis Toric Intraocular Lens.

Authors:  Wojciech Lubiński; Beata Kaźmierczak; Jolanta Gronkowska-Serafin; Karolina Podborączyńska-Jodko
Journal:  J Ophthalmol       Date:  2016-02-28       Impact factor: 1.909

7.  Visual Performance after Bilateral Implantation of a Four-Haptic Diffractive Toric Multifocal Intraocular Lens in High Myopes.

Authors:  John S M Chang; Vincent K C Chan; Jack C M Ng; Antony K P Law
Journal:  J Ophthalmol       Date:  2016-08-02       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.